Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

View 0 Studies Requested

Browse Lab Results > 2005-0021

Trial Summary

About CDAS Project, PI, Publications: Serum 25-hydroxyvitamin D, dietary vitamin D and non-Hodgkin Lymphoma: a Nested Case Control Study in the PLCO Trial

Datasets


Site: Endometrial

Inclusion Criteria:

  • No Prior History of Any Cancer
  • T0 Serum Available
  • No Uncontrolled Thaws
  • Female
  • Confirmed Post Menopausal
  • No Bilateral Oophorectomy at Baseline
  • No Hysterectomy at Baseline

Matching Factors:

  • Gender
  • Race
  • Age at Selection (+/- 1 year)
  • Month of Blood Draw (+/- 30 days)

Match Ratio: 1 to 1

Match Technique: Individual matching with replacement and cases as controls.


Analytes:

  • 25-Hydroxyvitamin D

Number of Cases: 155

Number of Controls: 155



Site: Lymphoid

Inclusion Criteria:

  • Has Signature
  • No Baseline Cancer
  • Has 2 Perfect T0 Serum Vials
  • Not Prevalent Cancer

Matching Factors:

  • Age at Randomization (5 year intervals)
  • Race
  • Gender
  • Season of Blood Draw
  • Study Year of Exit

Match Ratio: 1 to 1

Match Technique: Frequency matching with replacement and cases as controls (Incidence Density)


Analytes:

  • 25-Hydroxyvitamin D

Number of Cases: 297

Number of Controls: 296



Site: Ovary

Inclusion Criteria:

  • No Prior History of Any Cancer
  • T0 Serum Available
  • No Uncontrolled Thaws
  • Female
  • Confirmed Post Menopausal
  • No Bilateral Oophorectomy at Baseline

Matching Factors:

  • Gender
  • Race
  • Age at Selection (+/- 1 year)
  • Month of Blood Draw (+/- 30 days)

Match Ratio: 1 to 1

Match Technique: Individual matching with replacement and cases as controls.


Analytes:

  • 25-Hydroxyvitamin D

Number of Cases: 79

Number of Controls: 79



Site: Renal

Inclusion Criteria:

  • No Prior History of Any Cancer
  • T0 Serum Available
  • No Uncontrolled Thaws

Matching Factors:

  • Gender
  • Race
  • Age at Selection (+/- 1 year)
  • Month of Blood Draw (+/- 30 days)

Match Ratio: 1 to 1

Match Technique: Individual matching with replacement and cases as controls.


Analytes:

  • 25-Hydroxyvitamin D

Number of Cases: 163

Number of Controls: 163



Site: Upper GI

Inclusion Criteria:

  • No Prior History of Any Cancer
  • T0 Serum Available
  • No Uncontrolled Thaws

Matching Factors:

  • Gender
  • Race
  • Age at Selection (+/- 1 year)
  • Month of Blood Draw (+/- 30 days)

Match Ratio: 1 to 1

Match Technique: Individual matching with replacement and cases as controls.


Analytes:

  • 25-Hydroxyvitamin D

Number of Cases: 102

Number of Controls: 100